Toggle navigation
Home
Search
Services
Blog
Contact
About
Development-266030017
Acambis, Inc., Cambridge, MA, United States
Search grants from Acambis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
UC Davis-China Infectious Disease Research Training
Pathogenesis of Mcmv Infection
Border Biomedical Research Center: Administration
Data Collection of Pyruvate Dehydrogenase
A Twin-Family Study of Affective Disorders
Recently added grants:
Lipid Antigens for iNKT Cells in the Gut Microenvironment
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
Human B1-like Cells and Pneumococcal Defense in the Elderly
Maternal regulation of diet-induced obesity in offspring.
Mechanisms of improved organ function following sepsis treatment with vitamin c, thiamine and hydrocortisone (triple therapy)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI030017-002
Application #
6829008
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Acambis, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 2006
N01 AI
Development-266030017-266030017
/ Acambis, Inc.
NIH 2004
N01 AI
Development-266030017
/ Acambis, Inc.
NIH 2003
N01 AI
Development-266030017
/ Acambis, Inc.
Comments
Be the first to comment on this grant